What is Psyence Biomedical Ltd. Common Shares?
, an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in Phase IIb clinical study for the treatment of adjustment disorder in patients with cancer in a palliative care setting. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 12.00M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.